Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Autonomous voice telemedicine
Oxford-founded company behind Dora, a UKCA-marked AI voice assistant that conducts autonomous telephone follow-up calls for NHS patients, starting with cataract surgery.
The read
Ufonia's Dora is an AI voice assistant that autonomously telephones patients after routine procedures, starting with cataract surgery, asks a structured set of clinical questions, and flags any patient whose answers indicate they need a human clinician's review. It is built to sound and function like a standard telemedicine call, without requiring an app or a device.
Peer-reviewed evaluation assessed the accuracy and safety of Dora's autonomous cataract follow-up assessments, and the tool has been rolled out across more than a dozen NHS trusts, extending beyond cataract surgery into Long Covid and other routine follow-up conversations.
The Bridgehead view
Ufonia's UKCA marking for an autonomous conversational AI, not just a decision-support tool, is a genuinely unusual regulatory achievement, and the cataract-follow-up use case is a smart wedge: high-volume, low-complexity, and exactly where NHS capacity is most stretched.
Work with us
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
The firm that knows medtech
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.